MSNs-loaded HMME and Erastin-mediated ferroptosis combined with sonodynamic therapy for HCC treatment
These findings indicate that the nanoplatform can effectively alleviate tumor hypoxia while inducing apoptosis and ferroptosis, laying the foundation for enhancing the efficacy of ROS-mediated HCC therapy.
Authors
- Caixia Ling
- Danke Su (ORCID: https://orcid.org/0000-0001-7144-7238)
- Guchun Qin
- Chang Zhao
- Jinghang Jiang (ORCID: https://orcid.org/0000-0001-7019-5307)
- Zicheng Jiang (ORCID: https://orcid.org/0000-0002-8815-4551)
- Junjie Liu (ORCID: https://orcid.org/0000-0002-4096-7959)
- Yang Zhao (ORCID: https://orcid.org/0000-0003-1444-5927)
- Yunxi Huang (ORCID: https://orcid.org/0009-0007-2901-8406)
- Niqiang Zhou
Institutions
- Guangxi Medical University (CN)
- Guangxi Center for Disease Prevention and Control (CN)
Publication Details
- Journal
- Journal of Cancer Research and Therapeutics
- Published
- 2025-05-01
- DOI
- https://doi.org/10.4103/jcrt.jcrt_1531_24
- Citations
- 1
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.67